Water Main Break Advisory
We are open for business and taking extra preventative measures to keep you safe. Read more ❱❱
A systematic review of the comparative effectiveness and safety of phosphodiesterase type 5 (PDE-5) inhibitors in pediatric patients with pulmonary hypertension published Feb. 24, 2017 in Pediatrics demonstrates that scientific evidence supports the use of this class of medications in infants, neonates and children with pulmonary hypertension.
Emerging data from Children’s National Health System are providing hope that a new approach to cell therapy may effectively harness the cancer-killing potential of the natural immune system as a treatment for patients with blood and bone marrow cancers for whom stem cell transplantation has not worked.
The National Center for Advancing Translational Sciences
at the National Institutes of Health has awarded Children’s National Health System, in partnership with The George Washington University (GW), another prestigious Clinical and Translational Science Award.
The Washington Post and Kurt Newman address the issue of healthcare for children.
Children’s National Health System Urologist Michael Hsieh, M.D., was awarded a National Institutes of Health (NIH) grant to optimize a set of parasite proteins that could alleviate pain in multiple types of bladder inflammation.
Specific genetic errors that trigger congenital heart disease (CHD) in humans can be reproduced reliably in Drosophila melanogaster – the common fruit fly – an initial step toward personalized therapies for patients in the future.
Northern Virginia Magazine has named 64 Children’s National Health System physicians to its 2017 list of “Top Doctors.”
Adolescents seeking surgical treatment for severe obesity and its related conditions now can receive treatment at a nationally accredited program that meets the highest standards for patient safety and quality of care in the greater Washington, DC area.
Restoring neurogenic potential of neural stem/progenitor cells holds the promise of reducing long-term neurological deficits.
Children's National Health System, the nation’s largest provider of care for children with rare genetic disorders, announced it has formed the Children’s National Rare Disease Institute (CNRDI), a first-of-its-kind center focused exclusively on advancing the care and treatment of children and adults with rare genetic diseases.